Last reviewed · How we verify
Vicryl
At a glance
| Generic name | Vicryl |
|---|---|
| Also known as | Coated Polyglactin 910 without Triclosan |
| Sponsor | Tunis University |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Radiographic and Histological Assessment of GBR Using DBB Compared to Spontaneous Bone Regeneration of Maxillary Defects , Resulted From Enucleation of Intra-bony Cystic Lesions (NA)
- The Effect of Collagen Scaffold Augmentation in Achilles Tendon Rupture Repair (NA)
- Antibiotic-coated Braided Suture Study (NA)
- Study Comparing Transobturator Cystocele vs. Anterior Vaginal RepairS (NA)
- Polyurethane Foam Versus Gauze Dressing After Cesarean Delivery in a Standardized Surgical Setting: A Prospective Randomized Controlled Trial (NA)
- Autogenous Periosteal Pedicle Graft Versus Pericardium Membrane in Management of Periodontal Intrabony Defects in Stage III Periodontitis (NA)
- Interrupted Subdermal Suture Spacing During Linear Wound Closures and the Effect on Wound Cosmesis (NA)
- Novosyn® CHD vs Polyglactin 910 Suture to Close Wounds After Emergency or Elective Laparotomy or Laparoscopic Surgery
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Vicryl CI brief — competitive landscape report
- Vicryl updates RSS · CI watch RSS
- Tunis University portfolio CI